WHO WE ARE
As the only company solely focused on HIV, ViiV Healthcare is pioneering the way for HIV implementation science in the biopharmaceutical space.
We are committed to investing in implementation research alongside clinical efficacy trials to identify the best strategies for making a difference in the treatment and prevention of HIV.
In 2020, global statistics showed…
38 million People living with HIV
1.5 million People acquired HIV
Determining factors for successful implementation is necessary if we want to maximize the impact of available treatment and prevention strategies today and in the future. Implementation science can contribute to a better understanding of how to implement solutions and ensure that as many people benefit from the life-saving treatments and prevention medications for HIV.
Finding solutions to bridge the gap between clinical research and HIV care and prevention
Improving outcomes in HIV care and prevention – from increased testing, diagnosis, retention in care, and greater community viral load suppression – is a win-win for all, including individuals, public health community, researchers and industry.
We partner with researchers, public health leaders, academia, governments, community organizations, and others to increase the value and utilization of implementation research data with a clear focus on improving the lives of those affected by HIV and preventing acquisition of HIV.
- Global HIV & AIDS statistics-fact sheet. UNAIDS website. https://www.unaids.org/en/resources/fact-sheet
NP-GBL-HVU-WCNT-210007 | June 2021
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellowcard in the Google Play or Apple App store. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.